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The innate immune response is shaped by multiple factors, including both traditional autophagy and LC3-
associated phagocytosis (LAP). As the autophagic machinery is engaged during times of nutrient stress,
arising from scarcity or pathogens, we examine how autophagy, specifically LAP, and cellular metabolism
together influence macrophage function and the innate immune response.The principle of cellular homeostasis implies that cells must
constantly respond to internal and external stimuli in order to
maintain conditions compatible with viability. During an active
immune response, however, responding cells are subject to
frequent and dramatic shifts away from this homeostatic set
point in order to resolve the immunological insult. Many innate
immune cells must recognize, phagocytize, and process foreign
agents, as they encounter changes in nutrient and oxygen avail-
ability in inflamed or tumor microenvironments. Alterations in
cellular metabolism represent one of the fundamental mecha-
nisms bywhich cells maintain homeostasis, and intimately linked
with metabolism is the process of macroautophagy (hereafter
referred to as autophagy)—a highly conserved cellular pathway
designed to sequester portions of the cytoplasm for the purpose
of degrading long-lived proteins and generate nutrient sources
during times of metabolic stress (Levine et al., 2011). It is not sur-
prising, then, that autophagy is an important part of immune cell
function and shapes subsequent immune responses (Levine
et al., 2011). At the crossroads of immunity and autophagy, a
unique pathway has emerged in the form of LC3-associated
phagocytosis (LAP; Figure 1A), wherein receptor engagement
pathogens during engulfment elicits the rapid recruitment of
the autophagy machinery to the phagosome (Sanjuan et al.,
2009). Importantly, both pathogen clearance and immune
response are critically dependent on successful execution of
this pathway. Here, we focus on the first line of defense, phago-
cytic cells, and review how the autophagy machinery and meta-
bolism converge to influence the function of macrophages and
ultimately, the innate immune response to pathogens.
The Integration of Metabolic and Immunologic Signaling
Pathways
In response to pathogens or tissue damage, immune cells must
rapidly adapt their metabolic programs to meet specialized host
defense needs. Macrophages, like T cells, polarize into distinct
functional subtypes in response to different types of stimuli or
cytokine environment. The classical activation program in mac-
rophages (seen in M1 macrophages) is triggered by a combina-
tion of microbial components, such as lipopolysaccharide (LPS),
and interferon-g (IFN-g) (O’Neill and Hardie, 2013). M1 macro-
phages produce nitric oxide (NO), reactive oxygen species(ROS), and proinflammatory cytokines, such as TNF-a, inter-
leukin-1b (IL-1b), IL-6, and IL-12, thusmounting a rapid, effective
response against highly proliferative intracellular pathogens.
TheseM1macrophages have been shown to be potent effectors
against microorganisms and tumor cells (O’Neill and Hardie,
2013). In contrast, the alternative activation program (seen in
M2macrophages) attenuates excessive inflammation, promotes
tissue repair, and provides allergic and antiparasitic responses.
The M2 phenotype is generally considered to be anti-inflamma-
tory and driven by type 2 cytokines, such as IL-4 and IL-13
(O’Neill and Hardie, 2013).
Metabolic reprogramming is required for the divergent func-
tions of these two macrophage types. In M1 macrophages
(Figure 1B), a reconfiguration of metabolic programs from oxida-
tive phosphorylation to aerobic glycolysis and the pentose phos-
phate pathway (PPP) is integral to their host-defense properties
(O’Neill and Hardie, 2013). The mechanism of metabolic reprog-
ramming in M1 macrophages involves both transcriptional and
posttranslational regulation of metabolic enzymes. LPS-medi-
atedNOproduction results in selective S-nitrosylation of compo-
nents of the electron transport chain and metabolic enzymes in
mitochondria-dependent fatty-acid oxidation (FAO), leading to
suppression of mitochondria-dependent metabolism (Doulias
et al., 2013). Concomitantly, LPS stimulation results in significant
suppression of genes associated with the TCA cycle (O’Neill and
Hardie, 2013). LPS stimulation also rapidly triggers the transcrip-
tional induction of glucose transporter 1 (GLUT-1) and glycolytic
enzymes, including phosphoglycerate kinase (PGK) and ubiqui-
tous Phosphofructokinase 2 (uPFK2). Hypoxia-inducible factor
(HIF1), a transcriptional factor required for promotion of glycol-
ysis during tumorigenesis, is also essential for the regulation of
glycolysis and ATP production in M1 macrophages (Cramer
et al., 2003). While other mechanisms involved in the regulation
of glycolysis surely function in parallel, HIF1 is required for the
transcription of proinflammatory cytokines by M1 macrophages
in vitro and plays an essential role in regulating macrophage-
mediated inflammatory responses during rheumatoid joint
inflammation in vivo (Cramer et al., 2003). The polarization of
M1macrophages is also associated with a reduction in carbohy-
drate kinase-like protein CARKL, the activities of which limit the
routing of glucose into the PPP (Rodrı´guez-Prados et al., 2010).Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 895
Figure 1. LC3-Associated Phagocytosis
and Macrophage Metabolism
(A) Schematic representation of molecular mech-
anisms regulating LC3-associated phagocytosis.
Engagement of an extracellular receptor (such as
TLR, FcR, or PtdSer-R) by its ligand during
phagocytosis recruits members of the autophagy
machinery to the ligand-containing vesicle.
(B) Schematic representation of classical meta-
bolic activation (‘‘M1’’) of macrophages. Induced
by a combination of microbial components, such
as LPS and IFN-g, M1 macrophages utilize
aerobic glycolysis and the pentose phosphate
pathway (PPP) to produce nitric oxide (NO), reac-
tive oxygen species (ROS), and proinflammatory
cytokines to mount an effective response against
highly proliferative intracellular pathogens.
(C) Schematic representation of alternative
metabolic activation (‘‘M2’’) of macrophages.
Triggered by type 2 cytokines, such as IL-4 and IL-
13, the M2 phenotype is considered anti-inflam-
matory attenuates excessive inflammation, pro-
motes tissue repair, and provides allergic and
antiparasitic responses.
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competitive advantage against pathogens when an effective im-
mune response is fast and energy intensive. The upregulation of
glycolysis is required to maintain ATP production when access
to oxygen is limited (Nizet and Johnson, 2009). Additionally,
glucose can provide precursors for the lipid biosynthesis for
phagocytic intracellular membrane turnover. Further, glycolysis
rapidly depletes glucose stores and results in an acidic environ-
ment, both of which can be detrimental to rapidly proliferating
pathogens (Nizet and Johnson, 2009). As a reducing power,
NAPDH is required for maintaining reduced glutathione, limiting
oxidative stress, and serving as an essential cofactor for NADPH
oxidase-mediated ROS production and iNOS-mediated NO pro-
duction (Huang et al., 2009). While PPP can provide the pyridine
nucleotides NAD+ and NADP+, other processes can contribute896 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.to the intracellular NADPH pool. The
NADP+-specific forms of IDH (isocitrate
dehydrogenase) and ME (malic enzymes)
have been suggested to produce NAPDH
in macrophages upon LPS stimulation
(O’Neill and Hardie, 2013). Interestingly,
pharmacological inhibition of glycolysis
with 2-deoxyglucose abrogates macro-
phage-mediated inflammatory and anti-
microbial functions (Cramer et al., 2003).
In addition, genetic modulation of glyco-
lytic enzymes uPFK2, hexokinase (HK),
and CARLK suppresses LPS-induced in-
flammatory immune responses in macro-
phages (Rodrı´guez-Prados et al., 2010).
Collectively, these metabolic alterations
enable the inflammatory functions of M1
macrophages, and manipulation of these
metabolic programs can have a profound
impact on the immune outcome.
While M1 macrophages rely on mito-
chondria-independent catabolic path-ways, M2 macrophages (Figure 1C) primarily use the FAO
pathway and increased mitochondrial biogenesis to produce
ATP and reducing power for their metabolic needs. IL-4 robustly
induces signal transducer and activator of transcription 6
(STAT6), which works in concert with proliferator-activated re-
ceptor g (PPARg) coactivator-1b (PGC-1b) to induce expression
of genes involved in FAO and mitochondrial biogenesis and pro-
motes the transcription of Arginase-1 (Arg1) (O’Neill and Hardie,
2013). Arginase-1 shifts arginine catabolism from iNOS-medi-
ated production of NO to urea and ornithine production. In addi-
tion, regulation of cationic amino acid transporters (CATs) for
arginine uptake and argininosuccinate synthase 1 (ASS1)—
both needed for arginine recycling—add other layers of regula-
tion to arginine catabolism in the macrophage (Qualls et al.,
2012). Thus, the arginine catabolic pathway may represent a
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tion of macrophages.
Pharmacological inhibition of mitochondrial respiration or FAO
diminishes M2 macrophage immune functions. Consistent with
the idea of transcriptional coordination of metabolic programs
and other cellular processes, genetic ablation of metabolic reg-
ulators PGC-1b attenuates both metabolic and immune effector
functions in M2 macrophages, respectively (O’Neill and Hardie,
2013). In addition to cell-intrinsic effects, metabolic alterations
in macrophages can affect the extracellular microenvironment
by selectively depleting nutrients and secreting metabolites.
Upregulation of Arg1 in tumor-associated macrophages
(TAMs) results in the depletion of extracellular arginine and
secretion of NO or ornithine, which have destructive effects on
both tumor cells and infiltrated T cells (Nizet and Johnson,
2009; O’Neill and Hardie, 2013). Similarly, dendritic cells and
macrophages that express the tryptophan-catabolizing en-
zymes indoleamine 2,3-dioxygenase (IDO) and tryptophan-2,3-
dioxygenase (TDO) suppress T cell responses by depleting
tryptophan and secreting its catabolite, kynurinine (Yan et al.,
2010). Therefore, metabolic programming shapes the immune
response elicited during host defense, and, in turn, the immune
response shapes cellular metabolism to efficiently promote the
clearance of invading pathogens.
Autophagy: Molecular Mechanisms for ‘‘Self-Eating’’
and Host Defense
As self-sustaining entities, cells must be able to appropriately
employ a variety of mechanisms to maintain a supply of nutrients
and energy adequate for their survival. Therefore, similar to
altering cellular metabolism, the tightly regulated process of
autophagy also likely evolved as a response to cellular stress
and/or nutrient deprivation but also functions as a means of pro-
tein and organelle quality control (Levine et al., 2011). During
times of nutrient deprivation, autophagy is initiated by the release
of the preinitiation complex, composed of ULK1, ATG13, and
FIP200, from its mTOR-mediated inhibition (Kim et al., 2011).
Once active, the preinitiation complex releases the Beclin1-
VSP34-containing class III PI3K complex from the dynein motor
complex and allows it to function in the formation of the autopha-
gosome (Levine and Deretic, 2007). VPS34 generates the lipid
PI(3)P on the membranes of the forming phagophore, facilitating
the recruitment of additional protein complexes of the autopha-
gic machinery (Levine and Deretic, 2007). The elongation and
ultimate closure of the autophagosome is regulated by two ubiq-
uitylation-like protein conjugation systems: the ATG5-12-16L
and LC3-PE conjugation pathways. Whereas the large multi-
meric complexes of ATG5-12-16L serve as mechanical stabili-
zation for the forming autophagosome, LC3-PE or LC3-II, the
lipidated, membrane-associated form remains on the autopha-
gosome during its formation, its completion, and its fusion with
the lysosome and is therefore believed that LC3-II is crucial for
the targeting of autophagosomes to lysosomal organelles and,
ultimately, successful autophagy (Levine et al., 2011).
From a cellular perspective, it is perhaps not surprising that
a high degree of crosstalk exists between metabolic and auto-
phagic signaling pathways, and this interplay is a critical regu-
lator of functional outcome (Nizet and Johnson, 2009; O’Neill
and Hardie, 2013). One of the key molecules integrating a varietyof metabolic and autophagic signals is mTOR. mTORC1 activity
is a potent stimulator of cell growth through both induction
of protein translation and suppression of autophagy (Ma and
Blenis, 2009). Under conditions of amino acid abundance,
mTORC1 enhances ribosomal biogenesis and cap-dependent
messenger RNA (mRNA) translation, most likely through phos-
phorylation of the ribosomal protein S6K1 and the eukaryotic
initiation factor 4E-binding protein 1 (4EBP1) ((Ma and Blenis,
2009). In addition to its phosphorylation of ULK1 and ATG13,
mTORC1 may also regulate autophagy through interactions
with the transcription factor TFEB, a global regulator of auto-
phagy- and lysosome-associated genes. Evidence indicates
that amino acid starvation leads to decreased mTORC1 activity,
thus promoting nuclear localization of TFEB (Shanware et al.,
2013). During conditions of ample amino acids levels, the active
Ragulator complex directly binds tomTORC1; this interaction re-
sults in the localization of mTORC1 on the lysosome, essential
step in mTORC1 activation (Shanware et al., 2013). While it is
apparent that mTOR signaling mediates both metabolic and au-
tophagic changes in cells, much more work is needed to fully
characterize this relationship.
Another important signaling molecule on which metabolic and
autophagic pathways converge is AMPK.When ATP synthesis is
unable tomeet the demands of ATP consumption, AMP and ADP
accumulate and activate AMPK, resulting in the induction of fatty
acid oxidation for ATP production, while simultaneously sup-
pressing ATP-consuming activities such as protein synthesis,
fatty acid production, and other anabolic processes. Addition-
ally, active AMPK interacts with mTOR, suppresses mTORC1
activity, and indirectly promotes autophagy. AMPK also directly
enhances autophagy by phosphorylating and activating ULK1
(Shanware et al., 2013). In addition, AMPK can serve as an inti-
mate regulator of autophagy via its control of the VPS34 complex
during glucose starvation (Kim et al., 2013). Thus, AMPK
signaling promotes extensive metabolic reprogramming of cells
and combines this with cellular autophagy.
Cellular metabolism and autophagy can also converge at the
level of metabolites, which can act as signaling molecules and
initiate autophagy. Ammonia, for example, is produced during
glutaminolysis and appears to promote autophagy in tumor cells
in an ULK1-independent manner (Levine et al., 2011; Shanware
et al., 2013). Likewise, ATP is capable of inducing autophagy and
has been linked to the successful degradation of intracellular
mycobacterial infection (Levine and Deretic, 2007). Although
this area remains open to investigation, it is possible that the
intermediates and byproducts of different metabolic pathways
signal within the cell to engage autophagic (and likely other
metabolic) pathways. Thus, through classical signaling mole-
cules such as the mTOR and AMPK and through direct
interactions with metabolites, autophagy is tightly linked to the
metabolic profiles of cells.
As the autophagy pathway interacts with cellular metabolism,
its activity is also closely linked to the immune response. Just as
autophagy functions in the clearance of harmful, damaged pro-
teins or organelles, the autophagy machinery often interacts
with invading pathogens, such as Salmonella enterica, Listeria
monocytogenes, Mycobacterium tuberculosis, and Shigella
flexneri (Levine et al., 2011). Targeting of autophagic proteins
to intracellular infections (xenophagy) functions to quarantineCell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 897
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with monocytes deficient for ATG5 display enhanced suscepti-
bility to L. monocytogenes and T. gondii infection; similarly,
neuron-specific ATG5 deficiency increases susceptibility to
Sindbis virus infection. It is thought that autophagy can pro-
foundly impact innate immunity by impeding proinflammatory
cytokine production (Saitoh et al., 2008) and is required for
type I interferon responses in many but not all viral infections
(Henault et al., 2012; Levine et al., 2011). Moreover, the auto-
phagy machinery appears to be a critical regulator of the inflam-
masome activation pathway, with cells deficient for autophagy
protein (ATG16L) demonstrating increased IL-1b processing
(Saitoh et al., 2008).
Similar to cellular metabolism, the autophagic pathway can
also be regulated and manipulated by immune signaling mole-
cules. Activation of pathogen-recognition receptors, such as
Toll-like receptors (TLRs) and NOD-like receptors (NLRs), can
activate autophagy, as can exposure to damage associated
molecular patterns (DAMPs), such as ATP, ROS, and high-
mobility group box (HMGB) proteins (Levine and Deretic, 2007).
Whereas many of the mechanisms by which autophagy is regu-
lated by immune molecules are not understood, some interac-
tions have been elucidated. Beclin-1, a crucial member of the
class III PI3K complex, can be released from its inhibitory inter-
action with BCL2 via binding to MyD88, TRIF, or HMGB1 (Levine
et al., 2011). Likewise, ATG16L can interact with the intracellular
sensors, NOD1 and NOD2, triggering the recruitment of the
autophagic machinery to invasive bacteria. ATG16L also plays
a critical role in preventing Crohn’s disease, an inflammatory dis-
easeof thegastrointestinal tract.Micewith aPaneth-cell-specific
deletion of ATG16L display granule exocytosis abnormalities,
as well as an increased expression of genes involved in PPAR
signaling and lipid metabolism, and an increased expression
of adiponectin and leptin (Levine et al., 2011). Notably, Crohn’s
disease patients homozygous for the nonfunctional ATG16L
risk allele displayed a phenotype similar to those observed in
this ATG16L deficiencymousemodel (Hampe et al., 2007; Levine
et al., 2011). Therefore, the crosstalk between immunity and
autophagy can be initiated by both the pathogenic signals
presented by infection and the metabolic burden they incur.
LC3-Associated Phagocytosis
From the perspective of a single-celled organism, the two
ancient systems of phagocytosis and autophagy simply repre-
sent two modes of acquiring nutrients. Phagocytosis is utilized
when extracellular fuel is abundant, while autophagy is exploited
when nutrients are scarce. However, these scenarios become
decidedly more complex when one considers the engulfment
of pathogens. The interplay of phagocytosis and autophagy is
complicated by the activation of the immune response, as well
as the impending metabolic stress from such an interaction.
Recently, a process has been described that marries these con-
cepts into a fundamentally new way in which to think about the
impact of the autophagy machinery on innate host defense
mechanisms. LC3-associated phagocytosis (or LAP; Figure 1A)
is a unique process wherein an extracellular pathogen is sensed
and phagocytosed, and this engulfment recruits members of the
autophagy machinery to the pathogen-containing vesicle (San-
juan et al., 2007). It is the activity of these autophagic players898 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.that facilitates the rapid destruction of the pathogen via the lyso-
somal pathway. This is not macroautophagy, per se, but a
distinct process, and it is triggered upon phagocytosis of parti-
cles containing ligands that engage a receptor-mediated
signaling pathway. Indeed, the engagement of multiple types
of receptors, including TLR1/2, TLR2/6, TLR4, and FcR (Henault
et al., 2012; Sanjuan et al., 2007), can trigger the recruitment of
elements of the autophagy pathway to promote the rapid matu-
ration of the phagosome. LAP appears to proceed indepen-
dently of the preinitiation complex, yet it requires Beclin1,
ATG5, and ATG7 (Henault et al., 2012; Huang et al., 2009; Marti-
nez et al., 2011). Unlikemacroautophagy, the LC3 in LAP is asso-
ciated with a single- (not double-) membrane phagosome
(Sanjuan et al., 2009). In each of these settings, engagement of
LAP accelerates lysosomal fusion, acidification, and degrada-
tion of the phagocytosed cargo.
As the process of LAP links the recognition and phagocytosis
of pathogens to the autophagic machinery, it may not be surpris-
ing that LAP impacts upon the immune response as well. It has
been demonstrated that the engulfment of zymosan is associ-
ated with LAP, and macrophages deficient for ATG7 fail to effi-
ciently kill the intraphagosomal yeast (Sanjuan et al., 2007).
Further, the process of LAP can act as a defense mechanism
against autoimmune responses. Billions of cells die daily as a
result of stress, infection, or normal homeostasis. It is the re-
sponsibility of the phagocytes of the immune system, such as
macrophages, to rid the body of these cellular corpses, thus pre-
venting inflammation and autoimmunity. Phagocytes employ
numerous receptors and bridging molecules that directly recog-
nize phosphatidylserine (PtdSer), a lipid that resides exclusively
in the inner leaflet of the plasma membrane of healthy cells but is
exposed extracellularly when cells die. Mice deficient for these
receptors are often plagued by systemic lupus erythematosus
(SLE)-like autoimmune disorders, just as human SLE is charac-
terized by persistence of cell corpses. Therefore, uptake and
degradation of dying cells is a process crucial to maintaining ho-
meostasis (Han and Ravichandran, 2011). Importantly, LAP has
been demonstrated to play a critical role in the efficient clearance
of dying cells (Martinez et al., 2011). Engagement of the PtdSer
receptor, TIM4, results in recruitment of the autophagic machin-
ery to the dead-cell-containing, single-membrane phagosome.
Macrophages deficient for ATG7, however, fail to recruit LC3
to the phagosome, which results in failures in phagosomal acid-
ification and subsequent corpse degradation. Whereas the
phagocytosis and clearance of apoptotic cells is generally
considered an ‘‘immunologically silent’’ event, ATG7-deficient
macrophages produce dramatically increased levels of IL-1b
and IL-6 when fed apoptotic cells. Moreover, these ATG7-defi-
cient macrophages produce significantly less anti-inflammatory
cytokines, such as IL-10, upon such engulfment.
Failure to properly clear cellular corpses can result in the
release of self-autoantigens, which can trigger an inflammatory
response. Anti-nuclear antibodies (ANAs) can bind to DNA to
form DNA immune complexes (DNA-IC) that trigger type I IFN
by plasmacytoid dendritic cells (pDCs). This type I IFN response
requires both Fcg receptor (FcgR)-mediated internalization and
TLR9-mediated recognition of DNA-IC. Similarly, the hallmarks
of SLE include persistent TLR9 activation, the presence of
DNA-IC, and type I IFN production (Henault et al., 2012; Levine
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which DNA-IC triggers TLR9-mediated type I IFN production
has been poorly understood. It is now apparent that engagement
of the FcgR by the DNA-IC induces LAP, resulting in LC3 trans-
location to the DNA-IC-containing phagosome in an ATG5- and
ATG7-dependent manner (Henault et al., 2012). Strikingly, IFN-a
production was completely ablated in ATG7/, but not
ULK1/, pDCs in response to DNA-IC, suggesting that LAP
could affect the functional immune response elicited by this
autoantigen. Activation of the transcription factor responsible
for IFN-a production in pDCs, interferon regulatory factor 7
(IRF7), requires TLR9 trafficking into a specialized IRF7-signaling
compartment, associated with late-endolysosomal proteins.
Phagosomes from ATG7/ pDCs failed to acquire this late-
endolysosomal phenotype and instead persisted in an early-
endosomal stage, as evidenced by a continued association
with VAMP3 and a lack of association with LAMP1/2. Finally,
whereas wild-type cells showed robust nuclear translocation of
IRF7 in response to DNA-IC, ATG7/ cells did not. Collectively,
these data indicate that LAP is triggered upon engulfment of
DNA-IC and is essential for the maturation of the TLR9 compart-
ment into the IRF7 signaling compartment needed for type I IFN
production.
An area of growing interest is how a phagocyte handles the
metabolic stress of ingesting a cellular corpse and essentially
doubling its content of cellular components such as lipids, pro-
teins, and carbohydrates. The ‘‘find-me’’ signals, such as ATP,
released from dying cells can act as both autophagy inducers
and metabolites. Phagocytes that have engulfed apoptotic cells
increase their rate of FAO, a characteristic of M2 polarization.
Members of the peroxisome PPAR and liver x receptor (LXR)
families play an important role in maintaining cellular lipid ho-
meostasis, and recent studies have demonstrated roles for
PPARs and LXR in the clearance of apoptotic cells. Upon expo-
sure to apoptotic cells, phagocytes rapidly induce PPARg/d and
LXRs, which in turn result in the upregulation of phagocytic re-
ceptors and basal cholesterol efflux machinery to accommodate
the increase in lipid associated with engulfment (Han and Ravi-
chandran, 2011). Moreover, PPARg/ and PPARd/ macro-
phages show a defect in apoptotic cell uptake. Intriguingly,
PPARg/d are central players in the polarization of M2 macro-
phages, the phenotype of which is anti-inflammatory. As suc-
cessful LAP during the engulfment and degradation of dead cells
results in an anti-inflammatory cytokine response, the involve-
ment of PPARg and acquisition of an M2 phenotype is antici-
pated (Majai et al., 2007; Mukundan et al., 2009). Indeed, the
dual functions of PPARs and LXRs in both lipid apoptotic cell
clearance and lipid homeostasis suggests the interconnected-
ness between efferocytosis and metabolism.
Many solid tumors contain TAMs that clear dead cells from
within the tumor. As a consequence of their localization, TAMs
are often subjected to hypoxic conditions. While tumor cells
themselves upregulate glycolysis, it remains to be seen whether
TAMs also alter their energetic pathways, from an anti-inflamma-
toryM2 to a glycolytic M1 in order to survive the harsh conditions
of the tumor microenvironment (Nizet and Johnson, 2009). Inter-
estingly, glucose-rich cell culture conditions have been demon-
strated to reduce dead cell uptake by phagocytes. Conversely,
the efficiency of dead cell clearance fromwithin the tumormicro-environment could alter the metabolic profile of the tumor itself
(Han and Ravichandran, 2011).
Progression of atherosclerosis is also promoted by sustained
inflammation, and atherosclerotic plaques contain both
apoptotic and necrotic cells. Mice deficient for PPARs or LXRs
haveexacerbatedatherosclerosis, asdomicewithmacrophages
deficient for ATG5or ATG7 (Liao et al., 2012). These observations
suggest that LAP may be required to maintain an anti-inflamma-
tory environment and prevent the progression of atherosclerosis.
Another pathology that displaysdisturbances inbothmetabolism
and LAP is SLE. Indeed, SLE patient samples demonstrate
decreased FAO, indicating a defect in M2 macrophage polariza-
tion, as well as an increase in TNFa and IFN-g, both inducers of
the M1 phenotype. However, mouse models for SLE, such as
the PPARg/mouse, have an abundance of M2 macrophages,
and relapse of the disease is associated with increased M2
macrophage levels (Han and Ravichandran, 2011). The role the
autophagic (or specifically LAP) machinery plays in modulating
this metabolic programming remains to be determined.
Opsonization of bacterial pathogens or zymosan does not
seem to require or induce PPARg activation (Han and Ravichan-
dran, 2011), suggesting that signal specificity during LAP plays a
part in dictating both the immune response as well as the meta-
bolic response. We, and others, have observed that phagocy-
tosis of TLR- or FcR-conjugated particles induces not only LAP
but also ROS production (Huang et al., 2009; Martinez et al.,
2011; Sanjuan et al., 2009). It has been reported that ROS, spe-
cifically via the NADPH oxidase 2 (NOX2), is required for LC3
translocation to the particle-containing phagosome and NOX2-
deficient macrophages fail to engage the autophagic machinery
(Huang et al., 2009). As ROS production is a hallmark of M1mac-
rophages, it will be of great interest to determine how LAP func-
tions in shaping the metabolic programs of phagocytes.
Dissecting the crosstalk among phagocytosis, the autophagic
machinery, andmetabolic programming, especially as it pertains
to molding the innate immune response, is an area that is ripe
with potential for therapeutic intervention and a more complete
understanding of these intertwined processes. As both meta-
bolism and LC3-associated phagocytosis are critical regulators
of the innate immune response, how the two pathways impact
on each other is a priority. Moreover, the roles that each of these
play in shaping the adaptive immune response is one that will be
of great interest in the future. Cancer therapeutics have exploited
the uniquemetabolic needs of the tumor as amode of treatment.
It has been demonstrated that defective clearance of dead cells
can result in a variety of pathologies, such as atherosclerosis and
SLE-like autoimmunity, and many of these afflictions also
contain a metabolic component. As we become more knowl-
edgeable of the role of metabolic programming in immune func-
tion, the opportunity to develop new treatments for infection and
autoimmunity based on these same ideas will arise.
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